会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • METHODS FOR NUCLEIC ACID ANALYSIS
    • 核酸分析方法
    • WO2004070061A1
    • 2004-08-19
    • PCT/US2003/014799
    • 2003-05-08
    • PERLEGEN SCIENCES, INC.FRAZER, Kelly, A.PATIL, NilaSHEEHAN, John
    • FRAZER, Kelly, A.PATIL, NilaSHEEHAN, John
    • C12Q1/68
    • C12Q1/6809G06F19/18G06F19/22
    • The present invention provides methods for determining sequence similarity (conserved sequences) between nucleic acids from a first organism and nucleic acids from a second, different organism without having to know a priori the nucleic acid sequence from the second, different organism. The first nucleic acid can be from any organism where the sequence of the nucleic acid is known and the second nucleic acid can be from any organism. The method involves determining which bases from the second nucleic acid are identical to the first nucleic acid, and allows one to determine the sequence of portions of the second nucleic acid. The invention is useful for identifying putative functional regions or putative organism-sequences in a genome.
    • 本发明提供了用于确定来自第一生物体的核酸和来自第二种不同生物体的核酸之间的序列相似性(保守序列)的方法,而不必先验地知道来自第二种不同生物体的核酸序列。 第一核酸可以来自任何已知核酸序列并且第二核酸可以来自任何生物体的生物体。 所述方法包括确定来自第二核酸的哪些碱基与第一核酸相同,并且允许确定第二核酸的部分序列。 本发明可用于在基因组中鉴定推定的功能区域或推定的生物体序列。
    • 6. 发明申请
    • COMPOSITIONS AND METHODS FOR CANCER AND CANCER STEM CELL DETECTION AND ELIMINATION
    • 癌症和癌症干细胞检测和消除的组合物和方法
    • WO2013036867A2
    • 2013-03-14
    • PCT/US2012054307
    • 2012-09-07
    • UNIV CALIFORNIAJAMIESON CATRIONA HJIANG QINGFEIFRAZER KELLY ABARRETT CHRISTIANSADARANGANI ANILSHIH ALICECOURT ANGELE
    • JAMIESON CATRIONA HJIANG QINGFEIFRAZER KELLY ABARRETT CHRISTIANSADARANGANI ANILSHIH ALICECOURT ANGELE
    • A61K48/00
    • C07K16/40A61K31/7105A61K31/713A61K38/00C07K2/00C12N9/80C12N15/1137C12Y305/04004G01N33/57426G01N33/57484G01N2333/4703G01N2800/52
    • In alternative embodiments, the invention provides compositions and methods for inhibiting or ablating cancer stem cells. In alternative embodiments, the invention provides compositions and methods for inhibiting the action of double-stranded RNA-specific adenosine deaminases, or ADAR, enzymes. In alternative embodiments, the invention provides compositions and methods for treating, ameliorating or preventing diseases and conditions responsive to the inhibition of cell differentiation and/or self-renewal of dysfunctional cells, cancer cells, leukemia cells, hematopoietic stem cells or cancer stem cells, e.g., leukemia or Chronic Myeloid Leukemia (CML). In alternative embodiments, the invention provides compositions and methods for inhibiting a Sonic Hedgehog (Shh) pathway, e.g., by using a Smoothened (SMO) protein inhibitor. In alternative embodiments, the invention provides compositions and methods for measuring or determining, or predicting, chronic myelogenous leukemia (CML) progression, Leukemic Stem Cell (LSC) generation and/or tyrosine kinase inhibitor resistance. In alternative embodiments, the invention provides compositions and methods for determining or measuring the effectiveness of a treatment, a drug, a therapy or a diet for eliminating, killing or reducing the amounts of a leukemic stem cell (LSC) or cells.
    • 在替代实施方案中,本发明提供了用于抑制或消除癌症干细胞的组合物和方法。 在替代实施方案中,本发明提供了用于抑制双链RNA特异性腺苷脱氨酶或ADAR酶的作用的组合物和方法。 在可选的实施方案中,本发明提供了用于治疗,改善或预防对抑制功能失调细胞,癌细胞,白血病细胞,造血干细胞或癌症干细胞的细胞分化和/或自我更新有响应的疾病和病症的组合物和方法, 如白血病或慢性粒细胞白血病(CML)。 在可选的实施方案中,本发明提供了用于抑制Sonic Hedgehog(Shh)途径的组合物和方法,例如通过使用Smoothened(SMO)蛋白抑制剂。 在可选的实施方案中,本发明提供了用于测量或确定或预测慢性骨髓性白血病(CML)进展,白血病干细胞(LSC)产生和/或酪氨酸激酶抑制剂抗性的组合物和方法。 在可选的实施方案中,本发明提供了用于确定或测量用于消除,杀死或减少白血病干细胞(LSC)或细胞的量的治疗,药物,疗法或饮食的有效性的组合物和方法。